Stericycle (SRCL) Getting Somewhat Positive Press Coverage, Study Shows
Media stories about Stericycle (NASDAQ:SRCL) have been trending somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Stericycle earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned press coverage about the business services provider an impact score of 44.6563110750393 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:
- Stericycle (SRCL) Scheduled to Post Earnings on Wednesday (americanbankingnews.com)
- Reflections on Recalls: Five Years of the Stericycle Expert Solutions Recall Index (finance.yahoo.com)
- Zacks: Analysts Anticipate Stericycle Inc (SRCL) Will Announce Quarterly Sales of $880.51 Million (americanbankingnews.com)
- Comprehensive Stock Analysis – Stericycle Inc (NASDAQ: SRCL) – Alpha Beta Stock (alphabetastock.com)
Stericycle (NASDAQ SRCL) opened at $70.15 on Friday. Stericycle has a 1-year low of $61.25 and a 1-year high of $88.00. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a market cap of $5,990.00, a PE ratio of -125.27, a price-to-earnings-growth ratio of 1.77 and a beta of 0.26.
Several research firms recently issued reports on SRCL. BidaskClub cut shares of Stericycle from a “hold” rating to a “sell” rating in a report on Thursday, January 11th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. Royal Bank of Canada dropped their target price on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a report on Thursday, November 9th. BMO Capital Markets reaffirmed a “hold” rating and issued a $72.00 target price on shares of Stericycle in a report on Wednesday, January 24th. Finally, Oppenheimer reaffirmed a “hold” rating on shares of Stericycle in a report on Wednesday, December 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. Stericycle has a consensus rating of “Hold” and an average price target of $73.70.
In other news, Director Mark C. Miller sold 19,753 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $63.33, for a total value of $1,250,957.49. Following the sale, the director now directly owns 205,854 shares in the company, valued at $13,036,733.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 59,259 shares of company stock worth $3,847,687 over the last quarter. Company insiders own 3.50% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.